MAY 09, 2018 10:22 AM PDT

Valuable insights into better protein expression

WRITTEN BY: Jennifer Ellis

Pharmaceutical companies, biotech, and academia all have a hand in accelerating our understanding of proteins, whether through wide-ranging proteomics studies, more targeted investigations into a specific protein class, or large-scale bioproduction applicable to drug development. While protein studies are not always straightforward, advanced technologies can significantly improve quality and efficiency in any protein expression application.

Gibco’s ExpressionWorld, an upcoming virtual event covering advancements in protein expression, aims to unveil cutting-edge protein expression technologies and share case studies and best practices in biologics and vaccine development from discovery to production. The event features protein experts from a variety of disciplines discussing their work in a virtual setting, offering an opportunity for participants worldwide to expand their network and gain valuable advice.

LabCoat Live SmartStart Training virtual station

One such technology supports protein expression and the ability to produce quality and consistent high-titer proteins using specialized cell systems. Protein expression is typically dependent on stable cell line generation; however, improved results and more efficient workflows can be achieved using a novel standardized Expi expression system. Experts will explain how to use the system for high efficiency expression applicable to drug development through the generation of fusion proteins and monoclonal antibodies, which is traditionally a time-consuming and difficult process. Best practices suggested for the system emphasize obtaining high expression levels and improved quality over conventional stable cell line procedures.

Fundamental concepts and materials recommended for transient expression experiments and an outline of key differences between the primary cell lines used, most commonly HEK293 and CHO cell lines, will be discussed. Improved expression systems can not only provide higher quality protein products but can also expand efficiencies to candidate drug identification, reagent production, structural biology and vaccine research, and membrane protein biology.

The event will also explore various applications of the technologies, including analysis of G protein-coupled receptors (GPCRs) and unraveling how proteins function. GPCRs are well-known for regulating all known physiological processes and are common drug targets of interest. Using mammalian expression to generate GPCRs for downstream studies provides a versatile platform for high level GPCR expression, improving current limited knowledge of the biochemical and biophysical properties of GPCRs.

Further studies analyzing how proteins work is typically performed by detailed investigation into specific protein structures and complexes, with the ultimate goal of understanding the structure-function relationship of molecular machinery in their natural state. A new technology utilizing the success of Cryo Electron Microscopy (CryoEM) coupled to single particle analysis (SPA) offers accessible generation of three-dimensional protein reconstructions and has even resulted in medical breakthroughs that led to the 2017 Nobel Prize for Chemistry. Because CryoEM SPA works best on isolated and purified proteins, protein expression, isolation and purification are of extreme importance, particularly when evaluating structures in a functional context.

The availability of such knowledge within one platform, including a virtual training session with self-paced hands-on experiments guided by online lectures to increase retention and understanding of the concepts explained, provides a rare opportunity to accelerate one’s own research and benefit from these novel technologies to advance overall protein studies across different applications and disciplines.

About the Author
MS
I love all things science and am passionate about bringing science to the public through writing. With an M.S. in Genetics and experience in cancer research, marketing and technical writing, it is a pleasure to share the latest trends and findings in science on LabRoots.
You May Also Like
OCT 07, 2022
Genetics & Genomics
Epigenetic Marks Can Pass Down to Multiple Generations
OCT 07, 2022
Epigenetic Marks Can Pass Down to Multiple Generations
The earliest studies of genetic inheritance were very straightforward - Gregor Mendel documented the passage of certain ...
OCT 13, 2022
Immunology
SARS-CoV-2 Can Infect Fat Cells, Promoting Infection & Inflammation
OCT 13, 2022
SARS-CoV-2 Can Infect Fat Cells, Promoting Infection & Inflammation
SARS-CoV-2, the virus that causes COVID-19, is generally known to infect cells in the nose and respiratory tract by latc ...
NOV 06, 2022
Genetics & Genomics
The Lone Participant in a CRISPR Therapy Trial has Died
NOV 06, 2022
The Lone Participant in a CRISPR Therapy Trial has Died
In August of this year, a single patient was enrolled in a trial that used CRISPR to correct a genetic mutation that led ...
NOV 17, 2022
Plants & Animals
Creating living cells from dead Sumatran rhinoceros' tissue
NOV 17, 2022
Creating living cells from dead Sumatran rhinoceros' tissue
The Sumatran rhinoceros are considered a critically endangered species, with an estimated 80 or fewer Sumatran rhinos al ...
NOV 28, 2022
Neuroscience
Experimental Drug Halts Deadly Brain Cancer Growth Without Harming Brain Cells
NOV 28, 2022
Experimental Drug Halts Deadly Brain Cancer Growth Without Harming Brain Cells
  Researchers have found that blocking a certain enzyme halts the growth of a childhood brain cancer tumor. The cor ...
NOV 29, 2022
Genetics & Genomics
Eliminating 'Toxic' RNA Molecules to Treat ALS & Dementia
NOV 29, 2022
Eliminating 'Toxic' RNA Molecules to Treat ALS & Dementia
Researchers have developed a way to target RNA molecules that can have a harmful result. Instead of targeting the genome ...
Loading Comments...